Original Research

Published on 17 Sep 2024

Targeting FAK, VEGF, and MTA 1 Proteins with Terminalia elliptica: A Computational Approach for Anticancer Activity

in Pharmacology of Anti-Cancer Drugs

Shrivatsa Hegde
Bhargav Shreevatsa
Prakruthi N
Chandan D
Anisha Jain
Tanveer A Wani
Samudyata P Math
Shiva Prasad Kollur
Chandan Shivamallu

Frontiers in Oncology

doi 10.3389/fonc.2024.1427632

220 views

Correction

Accepted on 16 Sep 2024

Frontiers Corrigendum Template for Authors

in Pharmacology of Anti-Cancer Drugs

Xuehua Zhang
Leilei Zhao
Jinlong Xiao
Yudi Wang
Yunmeng Li
Chaoqun Zhu
He Zhang
Yurui Zhang
Xiao Zhu
Yucui Dong

Frontiers in Oncology

doi 10.3389/fonc.2024.1494738

Original Research

Published on 13 Sep 2024

Association of COX-inhibitors with cancer patients' survival under chemotherapy and radiotherapy regimens: a real-world data retrospective cohort analysis

in Pharmacology of Anti-Cancer Drugs

Lucas E Flausino
Isabella N Ferreira
Wen-Jan Tuan
Maria Del Pilar Estevez Diz
Roger Chammas

Frontiers in Oncology

doi 10.3389/fonc.2024.1433497

273 views

Case Report

Published on 13 Sep 2024

Disitamab vedotin (RC48) long-term regimen in a post-nephroureterectomy patient with metastases: A case report

in Pharmacology of Anti-Cancer Drugs

Suoshi Jing
Weiping Li
Bo Zhao
Wei Jiang
Bin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1419882

174 views

Review

Accepted on 09 Sep 2024

From Defense to Offense: Antimicrobial Peptides as Promising Therapeutics for Cancer

in Pharmacology of Anti-Cancer Drugs

Hadi Zare-Zardini
Elham Saberian
Andrej Jenča
Razieh Ghanipour-Meybodi

Frontiers in Oncology

doi 10.3389/fonc.2024.1463088

Original Research

Accepted on 09 Sep 2024

Anoikis in Prostate Cancer Bone Metastasis Gene Signatures and Therapeutic Implications

in Pharmacology of Anti-Cancer Drugs

Wei Xia
Miao Ye
Bo Jiang
Gang Xu
Guancheng Xiao
Qingming Zeng
Ruohui Huang

Frontiers in Oncology

doi 10.3389/fonc.2024.1446894

Review

Published on 09 Sep 2024

Lonicerae Japonicae Flos with the homology of medicine and food: A review of TCM theory, active ingredients, anticancer mechanisms and clinical applications

in Pharmacology of Anti-Cancer Drugs

Ping Ma
Ling Yuan
Shumin Jia
Ziying Zhou
Duojie Xu
Shicong Huang
Fandi Meng
zhe Zhang
Yi Nan

Frontiers in Oncology

doi 10.3389/fonc.2024.1446328

177 views

Original Research

Published on 09 Sep 2024

Efficacy of different medications in the treatment of gynaecological tumours: a clinical meta-analysis

in Pharmacology of Anti-Cancer Drugs

Qiaoying Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1428937

146 views

Original Research

Published on 05 Sep 2024

PCAF acetylates AIB1 to form a transcriptional coactivator complex to promote glycolysis in endometrial cancer

in Pharmacology of Anti-Cancer Drugs

Wu Di
Mingxia Li
Mingyang Wang
zhifeng yan
Yuanguang Meng

Frontiers in Oncology

doi 10.3389/fonc.2024.1442965

257 views

Systematic Review

Accepted on 04 Sep 2024

Administration Sequences in Single-Day Chemotherapy Regimens for Breast Cancer: A Comprehensive Review from a Practical Perspective

in Pharmacology of Anti-Cancer Drugs

Miaohui WU
Xiaoyan Huang
Meijun Chen
Yin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1353067

Review

Published on 29 Aug 2024

Metformin and Its Potential Influence on Cell Fate Decision between Apoptosis and Senescence in Cancer, with a Special Emphasis on Glioblastoma

in Pharmacology of Anti-Cancer Drugs

Melika Hajimohammadebrahim-Ketabforoush
Alireza Zali
Mohammadreza Shahmohammadi
Amir Ali Hamidieh

Frontiers in Oncology

doi 10.3389/fonc.2024.1455492

518 views

Original Research

Published on 29 Aug 2024

Sulforaphane regulates cell proliferation and induces apoptotic cell death mediated by ROS-cell cycle arrest in pancreatic cancer cells

in Pharmacology of Anti-Cancer Drugs

Yong Min Cho
Moon Nyeo Park
Min Choi
Tarun Kumar Upadhyay
Han Na Kang
Jeong Min Oh
Soonki Min
Ji-Ung Yang
Moonkyoo Kong
Seong-Gyu Ko

Frontiers in Oncology

doi 10.3389/fonc.2024.1442737

475 views

Case Report

Published on 29 Aug 2024

A novel secondary ALK gene mutation which resistant to second-generation TKIs: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Xiaqin Cheng
Jia Liu
Qiongxia Hu
Yingchun Gao
Lin Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1430350

246 views

Retraction

Published on 27 Aug 2024

Retraction: Disulfiram Chelated With Copper Inhibits the Growth of Gastric Cancer Cells by Modulating Stress Response and Wnt/β-catenin Signaling Author: Frontiers Editorial Office*

in Pharmacology of Anti-Cancer Drugs

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2024.1475033

210 views

Editorial

Published on 26 Aug 2024

Editorial: "Immune-checkpoint Inhibitors in Anti-cancer Armamentarium: A Double-edged Sword in Risk of Developing Autoimmunity and Immune-related Adverse Effects."

in Pharmacology of Anti-Cancer Drugs

Aysin Tulunay Virlan
Giacomo Cafaro
Flavia Sunzini
Yannick Degboé
Maria-Ioanna (Marianna) Christodoulou

Frontiers in Oncology

doi 10.3389/fonc.2024.1476475

409 views

Review

Published on 16 Jul 2024

Progress of natural sesquiterpenoids in the treatment of hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Xiaodong Wang
Fancheng Meng
Jingxin Mao

Frontiers in Oncology

doi 10.3389/fonc.2024.1445222

767 views

Navigation group

Articles

Targeting FAK, VEGF, and MTA 1 Proteins with Terminalia elliptica: A Computational Approach for Anticancer Activity

Frontiers Corrigendum Template for Authors

Association of COX-inhibitors with cancer patients' survival under chemotherapy and radiotherapy regimens: a real-world data retrospective cohort analysis

Disitamab vedotin (RC48) long-term regimen in a post-nephroureterectomy patient with metastases: A case report

From Defense to Offense: Antimicrobial Peptides as Promising Therapeutics for Cancer

Anoikis in Prostate Cancer Bone Metastasis Gene Signatures and Therapeutic Implications

Lonicerae Japonicae Flos with the homology of medicine and food: A review of TCM theory, active ingredients, anticancer mechanisms and clinical applications

Efficacy of different medications in the treatment of gynaecological tumours: a clinical meta-analysis

PCAF acetylates AIB1 to form a transcriptional coactivator complex to promote glycolysis in endometrial cancer

Administration Sequences in Single-Day Chemotherapy Regimens for Breast Cancer: A Comprehensive Review from a Practical Perspective

Metformin and Its Potential Influence on Cell Fate Decision between Apoptosis and Senescence in Cancer, with a Special Emphasis on Glioblastoma

Sulforaphane regulates cell proliferation and induces apoptotic cell death mediated by ROS-cell cycle arrest in pancreatic cancer cells

A novel secondary ALK gene mutation which resistant to second-generation TKIs: a case report and literature review

Retraction: Disulfiram Chelated With Copper Inhibits the Growth of Gastric Cancer Cells by Modulating Stress Response and Wnt/β-catenin Signaling Author: Frontiers Editorial Office*

Editorial: "Immune-checkpoint Inhibitors in Anti-cancer Armamentarium: A Double-edged Sword in Risk of Developing Autoimmunity and Immune-related Adverse Effects."

Progress of natural sesquiterpenoids in the treatment of hepatocellular carcinoma